Tuesday, 9th of September 2014 |
FOUR ITEMS ON MEASLES IMMUNE STATUS AND RESPONSE
IMMUNOGENICITY OF ATTENUATED MEASLES VIRUS ENGINEERED TO EXPRESS HELICOBACTER
PYLORI NEUTROPHIL-ACTIVATIN PROTEIN,
http://www.measlesupdates.org/?content=com_articles&artid=1975
PRIMING T-CELL RESPONSES WITH RECOMBINANT MEASLES VACCINE VECTOR IN A HETEROLOGOUS PRIME-BOOST SETTING IN NON-HUMAN PRIMATES
http://www.measlesupdates.org/?content=com_articles&artid=1976
RELEVANCE OF A PRE-EXISTING MEASLES IMMUNITY PRIOR IMMUNIZATION WITH A RECOMBINANT MEASLES VIRUS VECTOR
http://www.measlesupdates.org/?content=com_articles&artid=1977
IMMUNOGENICITY OF A RECOMBINANT MEASLES-HIV-A CLADE B CANDIDATE VACCINE,
http://www.measlesupdates.org/?content=com_articles&artid=1974
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
41219282 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |